Home LiteratureArticle Details
PMID: 17657310 Published · ppublish English Journal Article Research Support, N.I.H., Intramural

Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling.

The Journal of clinical investigation ·Vol. 117 ·No. 8 ·2007-08-00 ·Pages 2197-204

Paulos CM, Wrzesinski C, Kaiser A, Hinrichs CS, Chieppa M, Cassard L, Palmer DC, Boni A, Muranski P, Yu Z, Gattinoni L, Antony PA, Rosenberg SA, Restifo NP

Abstract

Lymphodepletion with total body irradiation (TBI) increases the efficacy of adoptively transferred tumor-specific CD8(+) T cells by depleting inhibitory lymphocytes and increasing homeostatic cytokine levels. We found that TBI augmented the function of adoptively transferred CD8(+) T cells in mice genetically deficient in all lymphocytes, indicating the existence of another TBI mechanism of action. Additional investigation revealed commensal gut microflora in the mesenteric lymph nodes and elevated LPS levels in the sera of irradiated mice. These findings correlated with increased dendritic cell activation and heightened levels of systemic inflammatory cytokines. Reduction of host microflora using antibiotics, neutralization of serum LPS using polymyxin B, or removal of LPS signaling components using mice genetically deficient in CD14 and TLR4 reduced the beneficial effects of TBI on tumor regression. Conversely, administration of microbial ligand-containing serum or ultrapure LPS from irradiated animals to nonirradiated antibody-lymphodepleted mice enhanced CD8(+) T cell activation and improved tumor regression. Administration of ultrapure LPS to irradiated animals further enhanced the number and function of the adoptively transferred cells, leading to long-term cure of mice with large B16F10 tumors and enhanced autoimmune vitiligo. Thus, disruption of the homeostatic balance between the host and microbes can enhance cell-based tumor immunotherapy.

MeSH Terms
Adoptive Transfer Animals Anti-Bacterial Agents/pharmacology Autoimmune Diseases/immunology,microbiology,pathology Autoimmunity/drug effects,immunology Bacterial Translocation/immunology,radiation effects CD8-Positive T-Lymphocytes/immunology,pathology,transplantation Cell Line, Tumor Cytokines/immunology Intestines/immunology,microbiology,pathology Lipopolysaccharide Receptors/immunology Lipopolysaccharides/immunology,pharmacology Lymphocyte Activation/drug effects,immunology Lymphocyte Depletion Mice Neoplasm Transplantation Neoplasms, Experimental/immunology,microbiology,pathology,therapy Polymyxin B/pharmacology Signal Transduction/drug effects,immunology Toll-Like Receptor 4/immunology Vitiligo/immunology,microbiology,pathology Whole-Body Irradiation
Chemicals
Anti-Bacterial Agents Cytokines Lipopolysaccharide Receptors Lipopolysaccharides Tlr4 protein, mouse Toll-Like Receptor 4 Polymyxin B
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Paulos Chrystal M
National Cancer Institute (NCI), NIH, Bethesda, Maryland 20892-1502, USA.
Wrzesinski Claudia
Kaiser Andrew
Hinrichs Christian S
Chieppa Marcello
Cassard Lydie
Palmer Douglas C
Boni Andrea
Muranski Pawel
Yu Zhiya
Gattinoni Luca
Antony Paul A
Rosenberg Steven A
Restifo Nicholas P
References (57)
57 references, click to expand
  1. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.
    Science. 2002 Oct 25;298(5594):850-4 PMID: 12242449
  2. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893.
    Clin Orthop Relat Res. 1991 Jan;(262):3-11 PMID: 1984929
  3. Toll-like receptors.
    Annu Rev Immunol. 2003;21:335-76 PMID: 12524386
  4. In vivo survival and homeostatic proliferation of natural killer cells.
    J Exp Med. 2003 Apr 21;197(8):967-76 PMID: 12695488
  5. Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy.
    Immunity. 2004 Jan;20(1):107-18 PMID: 14738769
  6. Toll-like receptors and dendritic cells: for whom the bug tolls.
    Semin Immunol. 2004 Feb;16(1):27-34 PMID: 14751761
  7. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance.
    Nat Immunol. 2004 May;5(5):508-15 PMID: 15064759
  8. CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction.
    J Immunol. 2004 May 15;172(10):5861-9 PMID: 15128765
  9. Symbiont recognition and subsequent morphogenesis as early events in an animal-bacterial mutualism.
    Science. 1991 Dec 6;254(5037):1491-4 PMID: 1962208
  10. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells.
    J Immunol. 1995 May 15;154(10):5071-9 PMID: 7730613
  11. Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration.
    J Immunol. 1995 Nov 15;155(10):5038-45 PMID: 7594512
  12. The indigenous gastrointestinal microflora.
    Trends Microbiol. 1996 Nov;4(11):430-5 PMID: 8950812
  13. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.
    Blood. 1997 Oct 15;90(8):3204-13 PMID: 9376604
  14. In vivo radioprotective effects of angiogenic growth factors on the small bowel of C3H mice.
    Radiat Res. 1998 Aug;150(2):204-11 PMID: 9692366
  15. Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease.
    J Clin Invest. 1998 Nov 15;102(10):1882-91 PMID: 9819375
  16. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.
    Science. 1998 Dec 11;282(5396):2085-8 PMID: 9851930
  17. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery.
    Immunity. 1999 Aug;11(2):173-81 PMID: 10485652
  18. Toll-like receptors: linking innate and adaptive immunity.
    Microbes Infect. 2004 Dec;6(15):1382-7 PMID: 15596124
  19. Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy.
    Trends Immunol. 2005 Feb;26(2):111-7 PMID: 15668127
  20. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.
    J Immunol. 2005 Mar 1;174(5):2591-601 PMID: 15728465
  21. Recent immune status determines the source of antigens that drive homeostatic T cell expansion.
    J Immunol. 2005 Mar 15;174(6):3158-63 PMID: 15749843
  22. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.
    J Clin Oncol. 2005 Apr 1;23(10):2346-57 PMID: 15800326
  23. Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells.
    J Clin Invest. 2005 Jun;115(6):1616-26 PMID: 15931392
  24. Regulation of immune responses by L-arginine metabolism.
    Nat Rev Immunol. 2005 Aug;5(8):641-54 PMID: 16056256
  25. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function.
    Science. 2005 Aug 26;309(5739):1380-4 PMID: 16123302
  26. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells.
    J Exp Med. 2005 Oct 3;202(7):907-12 PMID: 16203864
  27. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.
    J Immunol. 2006 Jan 1;176(1):157-64 PMID: 16365406
  28. Adoptive immunotherapy for cancer: building on success.
    Nat Rev Immunol. 2006 May;6(5):383-93 PMID: 16622476
  29. Hematopoietic stem-cell transplantation.
    N Engl J Med. 2006 Apr 27;354(17):1813-26 PMID: 16641398
  30. Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?
    Nat Clin Pract Oncol. 2006 Dec;3(12):668-81 PMID: 17139318
  31. Microbial translocation is a cause of systemic immune activation in chronic HIV infection.
    Nat Med. 2006 Dec;12(12):1365-71 PMID: 17115046
  32. The lymphopenic mouse in immunology: from patron to pariah.
    Immunity. 2006 Dec;25(6):851-5 PMID: 17174925
  33. Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation.
    Exp Hematol. 2007 Feb;35(2):184-92 PMID: 17258067
  34. Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells.
    J Clin Invest. 2007 Feb;117(2):492-501 PMID: 17273561
  35. Altered macrophage differentiation and immune dysfunction in tumor development.
    J Clin Invest. 2007 May;117(5):1155-66 PMID: 17476345
  36. Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery.
    Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):931-6 PMID: 11792864
  37. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.
    J Immunol. 1999 Nov 15;163(10):5211-8 PMID: 10553041
  38. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.
    Blood. 2000 May 1;95(9):2754-9 PMID: 10779417
  39. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.
    J Endotoxin Res. 2000;6(3):205-14 PMID: 11052175
  40. A Toll-like receptor recognizes bacterial DNA.
    Nature. 2000 Dec 7;408(6813):740-5 PMID: 11130078
  41. Molecular analysis of commensal host-microbial relationships in the intestine.
    Science. 2001 Feb 2;291(5505):881-4 PMID: 11157169
  42. Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo.
    Nat Immunol. 2000 Nov;1(5):426-32 PMID: 11062503
  43. Toll receptors in innate immunity.
    Trends Cell Biol. 2001 Jul;11(7):304-11 PMID: 11413042
  44. Innate immunity and inflammation: a transcriptional paradigm.
    Immunol Res. 2001;23(2-3):99-109 PMID: 11444396
  45. Innate immune recognition.
    Annu Rev Immunol. 2002;20:197-216 PMID: 11861602
  46. Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease.
    J Clin Invest. 2002 May;109(10):1335-44 PMID: 12021249
  47. Making room for T cells.
    J Clin Invest. 2002 Jul;110(2):157-9 PMID: 12122106
  48. T cell homeostatic proliferation elicits effective antitumor autoimmunity.
    J Clin Invest. 2002 Jul;110(2):185-92 PMID: 12122110
  49. Toll-like receptor signalling.
    Nat Rev Immunol. 2004 Jul;4(7):499-511 PMID: 15229469
  50. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells.
    J Exp Med. 2004 Sep 20;200(6):771-82 PMID: 15381730
  51. Toll-like receptor control of the adaptive immune responses.
    Nat Immunol. 2004 Oct;5(10):987-95 PMID: 15454922
  52. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.
    Transplantation. 1974 Oct;18(4):295-304 PMID: 4153799
  53. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides.
    Immunochemistry. 1976 Oct;13(10):813-8 PMID: 187544
  54. Specificity of adoptive chemoimmunotherapy of established syngeneic tumors.
    J Immunol. 1980 Aug;125(2):711-4 PMID: 6156213
  55. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.
    J Exp Med. 1982 Apr 1;155(4):1063-74 PMID: 6460831
  56. Approaching the asymptote? Evolution and revolution in immunology.
    Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:1-13 PMID: 2700931
  57. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.
    Science. 1990 Sep 21;249(4975):1431-3 PMID: 1698311
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
2007-08-00
Pages
2197-204
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC1924500
Subset
IM
Grants
Intramural NIH HHS · Z01 BC010763-01 · United States
Intramural NIH HHS · Z99 CA999999 · United States
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]